Exact Mass: 265.2154
Exact Mass Matches: 265.2154
Found 131 metabolites which its exact mass value is equals to given mass value 265.2154,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
Oxprenolol
Oxprenolol is only found in individuals that have used or taken this drug. It is a non-selective beta blocker with some intrinsic sympathomimetic activity. It is used for the treatment of angina pectoris, abnormal heart rhythms, anxiety, and high blood pressure. Oxprenolol is a lipophilic beta blocker which passes the blood-brain barrier more easily than water-soluble beta blockers. As such, it is associated with a higher incidence of CNS-related side effects than beta blockers with more hydrophilic molecules such as atenolol, sotalol, and nadolol (Wikipedia). Like other beta-adrenergic antagonists, oxprenolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, oxprenolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, oxprenolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Oxprenolol, therefore, inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
4-Hydroxy-alprenolol
4-Hydroxy-alprenolol is a metabolite of alprenolol. Alprenolol, or alfeprol, alpheprol, and alprenololum (Gubernal, Regletin, Yobir, Apllobal, Aptine, Aptol Duriles), is a non-selective beta blocker as well as 5-HT1A receptor antagonist, used in the treatment of angina pectoris. It is no longer marketed by AstraZeneca, but may still be available from other pharmaceutical companies or generically. (Wikipedia)
3-formamido-7,8-epoxy-alpha-bisabolane|N-(trans-1-methyl-4-[(2R*,3R*)-2-methyl-3-[(1E)-3-methylbut-1-en-1-yl]oxiran-2-yl]cyclohexyl)formamide
(9aS)-6t-furan-3-yl-3,9c-dimethyl-(9ar)-octahydro-quinolizine-3c,4xi-diol|Deoxynupharidin-6,7ss-diol|deoxynupharidine-6xi,7-diol
6-furan-3-yl-2-(3-methoxy-3-methyl-butyl)-3-methyl-piperidine|Nupharamin-methylaether
tetradecahydro-dipyrido[2,1-f;2,3-h][1,6]naphthyridin-8a-ol
8beta-amino-10beta-hydroxyeremophyl-7(11)-en-12,8alpha-olide|rel-(4aR,5S,8aS,9aS)-9a-amino-4a,5,6,7,8,8a,9,9a-octahydro-8a-hydroxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one
oxprenolol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3128 CONFIDENCE standard compound; INTERNAL_ID 2209
Mebeverine metabolite (1-Butanol, 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]-)
Coretal
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(2R,6R,7S,8S)-7-(but-3-en-1-yl)-2-propyl-1-azaspiro[5.5]undecan-8-ol
(5R)-6-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-5-methylhexan-2-one
(6R)-6-methyl-7-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)heptan-2-ol
(Z)-6-((R)-2-methyloctylidene)octahydroindolizin-8-ol
(1S,Z)-1-methyl-3-((R)-2-methylhexylidene)octahydro-2H-quinolizin-1-ol
((2S,3S,4R,7S,10S)-3,4,7,10-tetramethyldodecahydrocyclopenta[b]quinolizin-2-yl)methanol
4-amino-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine
2-methylpropyl 1-(furan-2-ylmethyl)piperidine-4-carboxylate
5-TERT-BUTYL-2-PIPERIDIN-1-YLMETHYL-FURAN-3-CARBOXYLIC ACID
5-TERT-BUTYL-2-METHYL-4-PYRROLIDIN-1-YLMETHYL-FURAN-3-CARBOXYLIC ACID
1,2-BENZENEDIOL, 4-[2-(DIBUTYLAMINO)ETHYL]-, HYDROBROMIDE
Etilefrine pivalate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent
2-(dimethylamino)ethanol,prop-2-enoic acid,styrene
3-Azaspiro[5.5]undec-7-ene-3-carboxylic acid, 9-oxo-, 1,1-diMethylethyl ester
TERT-BUTYL (4-HYDROXY-2-PHENYLBUTAN-2-YL)CARBAMATE
2-(6,7-diethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)ethanol
5-isobutyl-2-methyl-4-pyrrolidin-1-ylmethyl-furan-3-carboxylic acid
N-[(2,3,4-trimethoxyphenyl)methyl]cyclopentanamine
2,2,6,6-Tetramethyl-1,2,3,6-tetrahydro-4-pyridineboronic acid pinacol ester
4-(4(5)-Methyl-1H-imidazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester
N-methyl-1-(3,4,5-trimethoxyphenyl)pent-4-en-2-amine
N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanamine
N-(2-(diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide
Neramexane mesylate
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]-3-prop-2-enylphenol
(3R,4R,5R)-5-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4-diol
(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol
[(2S)-6-azaniumyl-1-oxo-1-[[(2S)-1-phenylpropan-2-yl]amino]hexan-2-yl]azanium
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
16-Hydroxy-7-aza-15-azoniatetracyclo[7.7.1.02,7.010,15]heptadecan-6-one
(2E,6E,10R)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate
(12R)-12-hydroxy-7-aza-15-azoniatetracyclo[7.7.1.02,7.010,15]heptadecan-6-one
17-Hydroxylupanine(1+)
An organic cation that is the conjugate acid of 17-hydroxylupanine, arising from protonation of the hemiaminal nitrogen; major species at pH 7.3.
1-(Tert-butylamino)-3-(2,4,6-trimethylphenoxy)-2-propanol
6-{(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}hexanoate
(2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate
Conjugate base of (2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoic acid.
